These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 19674504)

  • 1. Low-affinity Fcgamma receptors, autoimmunity and infection.
    Willcocks LC; Smith KG; Clatworthy MR
    Expert Rev Mol Med; 2009 Aug; 11():e24. PubMed ID: 19674504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies capable of discriminating the human inhibitory Fcgamma-receptor IIB (CD32B) from the activating Fcgamma-receptor IIA (CD32A): biochemical, biological and functional characterization.
    Veri MC; Gorlatov S; Li H; Burke S; Johnson S; Stavenhagen J; Stein KE; Bonvini E; Koenig S
    Immunology; 2007 Jul; 121(3):392-404. PubMed ID: 17386079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc receptors and their interaction with complement in autoimmunity.
    Schmidt RE; Gessner JE
    Immunol Lett; 2005 Aug; 100(1):56-67. PubMed ID: 16125792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc optimization of therapeutic antibodies enhances their ability to kill tumor cells in vitro and controls tumor expansion in vivo via low-affinity activating Fcgamma receptors.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Vijh S; Johnson S; Bonvini E; Koenig S
    Cancer Res; 2007 Sep; 67(18):8882-90. PubMed ID: 17875730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can antibodies with specificity for soluble antigens mimic the therapeutic effects of intravenous IgG in the treatment of autoimmune disease?
    Siragam V; Brinc D; Crow AR; Song S; Freedman J; Lazarus AH
    J Clin Invest; 2005 Jan; 115(1):155-60. PubMed ID: 15630455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and receptor binding of IgG1 peptides derived from the IgG Fc region.
    Uray K; Medgyesi D; Hilbert A; Sármay G; Gergely J; Hudecz F
    J Mol Recognit; 2004; 17(2):95-105. PubMed ID: 15027030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FcgammaR: The key to optimize therapeutic antibodies?
    Sibéril S; Dutertre CA; Fridman WH; Teillaud JL
    Crit Rev Oncol Hematol; 2007 Apr; 62(1):26-33. PubMed ID: 17240158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C5a and Fcgamma receptors: a mutual admiration society.
    Atkinson JP
    J Clin Invest; 2006 Feb; 116(2):304-6. PubMed ID: 16453017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allergy and autoimmunity mediated by IgG and Fcgamma receptors].
    Takai T
    Arerugi; 2005 Oct; 54(10):1183-9. PubMed ID: 16407664
    [No Abstract]   [Full Text] [Related]  

  • 11. FcγRs in health and disease.
    Nimmerjahn F; Ravetch JV
    Curr Top Microbiol Immunol; 2011; 350():105-25. PubMed ID: 20680807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FcgammaRIIB as a modulator of autoimmune disease susceptibility.
    Tarasenko T; Dean JA; Bolland S
    Autoimmunity; 2007 Sep; 40(6):409-17. PubMed ID: 17729034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the pathophysiology and in vivo function of IgG Fc receptors through gene deletion studies.
    Baumann U; Schmidt RE; Gessner JE
    Arch Immunol Ther Exp (Warsz); 2003; 51(6):399-406. PubMed ID: 14692661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IVIG therapy: interfering with interferon-gamma.
    Clynes R
    Immunity; 2007 Jan; 26(1):4-6. PubMed ID: 17241954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel roles for the IgG Fc glycan.
    Anthony RM; Wermeling F; Ravetch JV
    Ann N Y Acad Sci; 2012 Apr; 1253():170-80. PubMed ID: 22288459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases.
    Yu Z; Lennon VA
    N Engl J Med; 1999 Jan; 340(3):227-8. PubMed ID: 9895405
    [No Abstract]   [Full Text] [Related]  

  • 17. The IgG Fc receptor family.
    Gessner JE; Heiken H; Tamm A; Schmidt RE
    Ann Hematol; 1998 Jun; 76(6):231-48. PubMed ID: 9692811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic and copy-number variations of FcγRs affect granulocyte function and susceptibility for autoimmune blistering diseases.
    Recke A; Vidarsson G; Ludwig RJ; Freitag M; Möller S; Vonthein R; Schellenberger J; Haase O; Görg S; Nebel A; Flachsbart F; Schreiber S; Lieb W; Gläser R; Benoit S; Sárdy M; Eming R; Hertl M; Zillikens D; König IR; Schmidt E; Ibrahim S;
    J Autoimmun; 2015 Jul; 61():36-44. PubMed ID: 26032265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetramolecular immune complexes are more efficient than IVIg to prevent antibody-dependent in vitro and in vivo phagocytosis of blood cells.
    Bazin R; Lemieux R; Tremblay T; St-Amour I
    Br J Haematol; 2004 Oct; 127(1):90-6. PubMed ID: 15384982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiinflammatory activity of IgG: the intravenous IgG paradox.
    Nimmerjahn F; Ravetch JV
    J Exp Med; 2007 Jan; 204(1):11-5. PubMed ID: 17227911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.